NNOX (NNOX) Stock Price & Analysis

NNOX (NNOX) fell 7.97% to USD 0.9 as of July 25, 2026 at 03:49 UTC, according to Nexqual real-time market data.

NNOX last closed at USD 0.97; the session ranged USD 0.87–0.98 on volume of 1,328,436 shares. Market capitalization is $62.38M, with a 52-week range of USD 0.73–5.26 (NGM). Source: Nexqual, July 25, 2026 at 03:49 UTC.

Key Statistics (as of July 25, 2026 at 03:49 UTC)

PriceUSD 0.9
Change▼ 7.97% (down)
Previous CloseUSD 0.97
OpenUSD 0.96
Day RangeUSD 0.87 – 0.98
52-Week RangeUSD 0.73 – 5.26
Volume1,328,436 shares
Market Cap$62.38M
ExchangeNGM

Technical Analysis (NNOX)

Nexqual's technical model rates NNOX "SELL" based on 2 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 03:49 UTC.

Overall SignalSELL
RSI (14)29.16 (oversold)
vs SMA50Below (USD 1.51)
MACD-0.15 (negative)

Analyst Ratings (NNOX)

Wall Street analysts rate NNOX "None" based on 3 analysts, with a mean price target of USD 5.13 (range USD 3–7.4), per Nexqual as of July 25, 2026 at 03:49 UTC.

Consensus RatingNone
Analyst Count3
Mean TargetUSD 5.13
High TargetUSD 7.4
Low TargetUSD 3
Buy / Hold / Sell2 / 1 / 0

Earnings (NNOX)

Next Earnings Date2026-08-12
EPS EstimateUSD -0.12
Revenue Estimate$5.39M

Recent Earnings History

QuarterActual vs Estimate
2026-03-31USD -0.16 vs est -0.14 ▼ miss
2025-12-31USD -0.17 vs est -0.15 ▼ miss
2025-09-30USD -0.15 vs est -0.18 ▲ beat
2025-06-30USD -0.17 vs est -0.15 ▼ miss

Source: Nexqual, July 25, 2026 at 03:49 UTC.

Financials & Fundamentals (NNOX)

Total Revenue$14.52M
Revenue Growth (YoY)+53.10%
Gross Margin-84.91%
Operating Margin-337.05%
Profit Margin+0.00%
ROE-50.12%
Debt / Equity6.05
Current Ratio3.64
Total Cash$43.85M
Total Debt$7.64M
Free Cash Flow$-28.92M

Source: Nexqual, July 25, 2026 at 03:49 UTC.

Financial Health Score (NNOX)

Nexqual rates NNOX's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 03:49 UTC.

GrowthStrong — Revenue +15% YoY (annual)
ProfitabilityCritical — Heavily loss-making — early-stage company
Balance SheetStrong — $44M cash vs $8M debt, net cash position
Cash FlowWeak — FCF negative: -$29M, burning cash
EfficiencyCritical — ROE -50%, ROA -22.3%

Ownership (NNOX)

Insider Ownership+7.91%
Institutional Ownership+26.71%
Shares Outstanding69.60M
Float64.11M
Short % of Float+10.33%

Source: Nexqual, July 25, 2026 at 03:49 UTC.

Leadership (NNOX)

NNOX is led by Erez I. Meltzer (age 68), CEO & Acting Chairman of the Board, per Nexqual as of July 25, 2026 at 03:49 UTC.

CEO & Acting Chairman of the BoardErez I. Meltzer (age 68)
Chief Financial OfficerRan Daniel (age 57)
Executive VP & Chief Marketing OfficerTamar Aharon Cohen (age 48)
President & CMO, USARAD Holdings Inc.Michael Yuz

Major Backers & Investors (NNOX)

Notable institutional backers of NNOX include Weiss Asset Management Lp, ARK Invest, UBS Group AG, according to Nexqual as of July 25, 2026 at 03:49 UTC.

Active Investors

InvestorStake
Weiss Asset Management Lp4.01%
ARK Invest2.21%
UBS Group AG1.94%
Fidelity0.99%
National Bank of Canada/FI/0.82%
AQR Capital Management, LLC0.71%

Index Funds (Passive)

FundStake
BlackRock9.12%
State Street2.03%
Geode Capital1.28%
Northern Trust0.75%

Source: Nexqual, July 25, 2026 at 03:49 UTC.

Peers & Related Stocks

SymbolNamePriceChange
RXRXRecursion Pharmaceuticals, Inc.USD 2.96▼ 0.67%
NNDMNano Dimension Ltd.USD 1.47▼ 0.68%
FUBOfuboTV Inc.USD 8.33▼ 7.34%
EHEHang Holdings LimitedUSD 4.9▼ 6.4%
AMWLAmerican Well CorporationUSD 10.81▼ 7.29%

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:49 UTC. This page is informational and not investment advice.